Bank of Montreal,
Healthcare of Ontario Pension Plan Trust Fund, and
BNP Paribas Financial Markets have increased their holdings in
Illumina (NASDAQ:ILMN), while
Dynamic Technology Lab Private Ltd has sold a significant portion of its shares. An insider also increased their holding. Meanwhile,
Illumina acquired
Fluent BioSciences to expand its single-cell analysis capabilities. Performance of
Illumina shares came under pressure due to constrained spending in the pharmaceutical industry. However, the company retained a strong position in its niche market. The company's
TruSight Oncology portfolio has been expanded and
Q3 earnings showed positive results, surpassing Wall Street estimates. The board approved the spin-off of
GRAIL despite lowered 2024 revenue guidance. The company also launched new low-cost gene sequencing devices. A European court of justice ruled in favor of Illumina in a jurisdictional appeal.
Illumina ILMN News Analytics from Tue, 30 Jan 2024 08:00:00 GMT to Sat, 30 Nov 2024 10:06:26 GMT -
Rating 7
- Innovation 8
- Information 9
- Rumor 4
